Market Overview

Benzinga's Top Upgrades, Downgrades For December 22, 2016

Share:

Top Upgrades

  • Analysts at Summit Redstone Partners upgraded Micron Technology, Inc. (NASDAQ: MU) from Sell to Buy. Micron shares rose 12.05 percent to $23.06 in pre-market trading.
  • Baird upgraded AMETEK, Inc. (NYSE: AME) from Neutral to Outperform. AMETEK shares fell 0.34 percent to close at $49.30 on Wednesday.
  • Citigroup upgraded Merus NV (NASDAQ: MRUS) from Neutral to Buy. Merus shares gained 0.40 percent to $20.30 in pre-market trading.
  • FBR Capital upgraded Sunoco LP (NYSE: SUN) from Market Perform to Outperform. Sunoco shares rose 6.32 percent to close at $23.54 on Wednesday.
  • Analysts at Mizuho upgraded Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) from Neutral to Buy. Sucampo Pharmaceuticals shares rose 0.78 percent to $12.95 in pre-market trading.
  • Needham & Company upgraded Micron Technology (NASDAQ: MU) from Underperform to Buy. Micron shares rose 12.05 percent to $23.06 in pre-market trading.
  • Analysts at Baird upgraded National Instruments Corp (NASDAQ: NATI) from Neutral to Outperform. National Instruments shares fell 0.46 percent to close at $30.06 on Wednesday.


Top Downgrades

  • SunTrust Robinson Humphrey downgraded Procter & Gamble Co (NYSE: PG) from Buy to Hold. Procter & Gamble shares fell 0.50 percent to $83.86 in pre-market trading.
  • Analysts at Wells Fargo downgraded Swift Transportation Co (NYSE: SWFT) from Outperform to Market Perform. Swift Transportation shares fell 0.49 percent to close at $24.48 on Wednesday.
  • BMO Capital downgraded Greif, Inc. (NYSE: GEF) from Market Perform to Underperform. Greif shares fell 0.57 percent to close at $53.81 on Wednesday.
  • Raymond James downgraded Bed Bath & Beyond Inc. (NASDAQ: BBBY) from Strong Buy to Market Perform. Bed Bath & Beyond shares fell 4.39 percent to $43.56 in pre-market trading.
  • Analysts at B. Riley downgraded Stage Stores Inc (NYSE: SSI) from Neutral to Sell. Stage Stores shares fell 0.56 percent to close at $5.31 on Wednesday.
  • Stifel Nicolaus downgraded Red Hat Inc (NYSE: RHT) from Buy to Hold. Red Hat shares fell 12.06 percent to $70.17 in pre-market trading.
  • Analysts at Canaccord Genuity downgraded Finish Line Inc (NASDAQ: FINL) from Buy to Hold. Finish Line shares fell 2.67 percent to $20.44 in pre-market trading.
  • Pacific Crest downgraded InvenSense Inc (NYSE: INVN) from Overweight to Sector Weight. InvenSense shares fell 0.08 percent to $12.74 in pre-market trading.
  • B. Riley downgraded Zumiez Inc. (NASDAQ: ZUMZ) from Buy to Neutral. Zumiez shares fell 2.41 percent to $22.25 in pre-market trading.


Top Initiations

 

  • Analysts at BTIG Research initiated coverage on CoLucid Pharmaceuticals Inc (NASDAQ: CLCD) with a Buy rating. The price target for CoLucid Pharmaceuticals is set to $58. CoLucid Pharmaceuticals shares closed at $36.15 on Wednesday.
  • Analysts at JP Morgan initiated coverage on Sarepta Therapeutics Inc (NASDAQ: SRPT) with an Overweight rating. The price target for Sarepta Therapeutics is set to $40. Sarepta Therapeutics shares closed at $29.49 on Wednesday.
  • Analysts at Drexel Hamilton initiated coverage on Power Integrations Inc (NASDAQ: POWI) with a Buy rating. Power Integrations shares closed at $67.65 on Wednesday.
  • Analysts at BMO Capital initiated coverage on Healthcare Realty Trust Inc (NYSE: HR) with a Market Perform rating. The price target for Healthcare Realty Trust is set to $31. Healthcare Realty Trust shares closed at $29.39 on Wednesday.
  • Analysts at Raymond James initiated coverage on Flexion Therapeutics Inc (NASDAQ: FLXN) with a Strong Buy rating. Flexion Therapeutics shares closed at $18.18 on Wednesday.
  • Analysts at Guggenheim initiated coverage of Akamai Technologies, Inc. (NASDAQ: AKAM) with a Buy rating. The price target for Akamai Technologies is set to $75. Akamai Technologies shares closed at $67.87 on Wednesday.
  • Analysts at Piper Jaffray initiated coverage on Microsoft Corporation (NASDAQ: MSFT) with an Overweight rating. The price target for Microsoft is set to $80. Microsoft shares closed at $63.54 on Wednesday.
  • Jefferies initiated coverage on Radware Ltd. (NASDAQ: RDWR) with a Buy rating. The price target for Radware is set to $18.50. Radware shares closed at $14.31 on Wednesday.
  • Aegis Capital initiated coverage on Wynn Resorts, Limited (NASDAQ: WYNN) with a Neutral rating. The price target for Wynn Resorts is set to $87. Wynn Resorts shares closed at $89.27 on Wednesday
  • Leerink Swann initiated coverage on Cardiome Pharma Corp (NASDAQ: CRME) with an Outperform rating. Cardiome Pharma shares closed at $2.70 on Wednesday.

Latest Ratings for AME

DateFirmActionFromTo
Dec 2018UpgradesEqual-WeightOverweight
Nov 2018Initiates Coverage OnOverweight
Nov 2018MaintainsEqual-WeightEqual-Weight

View More Analyst Ratings for AME
View the Latest Analyst Ratings

Posted-In: Benzinga's Top Upgrades Downgrades InitiationsUpgrades Downgrades Initiation Analyst Ratings

 

Related Articles (AKAM + AME)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
SPSCUpgrades
OMCLDowngrades
CARODowngrades
HFWADowngrades
CLFUpgrades14.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

U.S. Dollar Index Little Lower, FHFA House Prices Edge Up

The Sell-Side Reaction To Nike's Q2